乌鸦传媒

<乌鸦传媒 class="page-title">Meeting Coverage

AANEM

<乌鸦传媒 class="page-description">American Association of Neuromuscular & Electrodiagnostic Medicine
Botulinum Toxin Injection May Be an Option for Excess Saliva in Patients With ALS

Small VA-based study saw promising short-term results with no adverse events

image
<乌鸦传媒 class="section_title">Latest AANEM Meeting Coverage
Efgartigimod Offers Hope in Chronic Inflammatory Demyelinating Polyneuropathy

Subcutaneous formulation lowers relapse risk in debilitating autoimmune disorder

November 5, 2023
Rozanolixizumab Maintains Efficacy Among Generalized Myasthenia Gravis Subgroups

Benefits maintained after multiple treatment cycles

November 3, 2023
Novel C1s Inhibitor Shows Promising Activity in Rare Neurologic Disorder

44% of treated patients with CIDP showed improvement after switching to riliprubart

November 3, 2023
Eculizumab Substantially Reduces Myasthenia Gravis Events

Hospitalization dropped threefold, real-world data show

November 2, 2023
Lambert-Eaton Myasthenic Syndrome Underdiagnosed Alongside SCLC in the U.S.

Findings suggest patients with SCLC are not screened for LEMS, despite their association

November 2, 2023
<乌鸦传媒 class="section_title"> Latest Neurology Meeting Coverage